[Drug-induced lupus erythematosus-like syndromes].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis; D000927:Anticonvulsants / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects; D006830:Hydralazine / Q000009:adverse effects; D007538:Isoniazid / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000175:diagnosis; D008214:Lymphocytes; D008297:Male; D008875:Middle Aged; D011342:Procainamide / Q000009:adverse effects
D000974:Antibodies, Antinuclear; D000927:Anticonvulsants; D006827:Hydantoins; D006830:Hydralazine; D011342:Procainamide; D007538:Isoniazid
Arzneimittelinduzierte Lupus-erythematodes-ähnliche Syndrome